Shanghai Micurx Pharmaceutical Co., Ltd. Class ASSE: 688373

Announcement on Reply to Letter of Supervision and Inquiry on Information Disclosure of 2024 Annual Report

· Issued by Shanghai Micurx Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Reply to Letter of Supervision and Inquiry on Information Disclosure of 2024 Annual Report

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis